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AbsTrACT
Universal health coverage (UHC) is driving the global health 
agenda. Many countries have embarked on national policy 
reforms towards this goal, including China. In 2009, the 
Chinese government launched a new round of healthcare 
reform towards UHC, aiming to provide universal coverage 
of basic healthcare by the end of 2020. The year of 
2019 marks the 10th anniversary of China’s most recent 
healthcare reform. Sharing China’s experience is especially 
timely for other countries pursuing reforms to achieve 
UHC. This study describes the social, economic and health 
context in China, and then reviews the overall progress of 
healthcare reform (1949 to present), with a focus on the 
most recent (2009) round of healthcare reform. The study 
comprehensively analyses key reform initiatives and major 
achievements according to four aspects: health insurance 
system, drug supply and security system, medical service 
system and public health service system. Lessons learnt 
from China may have important implications for other 
nations, including continued political support, increased 
health financing and a strong primary healthcare system 
as basis.
InTroduCTIon
Universal health coverage (UHC) is driving 
the global health agenda and is now an ambi-
tion for many nations at all stages of devel-
opment.1 2 UHC is a means for achieving 
improved equity, health, financial well- being 
and economic development, ensuring that 
everyone has access to quality, affordable 
health services when needed.3 Most countries 
have made UHC a key global health objective 
through the United Nations’ resolution, and 
move towards UHC following the Sustainable 
Development Goals (SDG) set in 2015. At 
the beginning of the 21st century, the push 
for UHC seems stronger than ever.4 The new 
WHO director general, Dr Tedros, empha-
sised that UHC is the ‘top strategic priority’ 
in the road map for WHO’s renewal.5 Accord-
ingly, WHO’s General Program of Work 
for 2019–2023 has set an ambitious goal of 
benefiting more than 1 billion people from 
UHC by 2023.6
WHO states that there is ‘no one size to 
fit all’—there are different ways to attain 
UHC. An increasing number of low and 
middle- income countries (LMIC) are actively 
pursuing policies to achieve UHC and share 
their implementation experience from 
different political settings, such as Turkey,7 
Indonesia,8 Thailand9 and Bangladesh.10 
According to The World Bank report, the 
march to UHC in China is unparalleled.11 
Also, Yip et al commented that ‘China’s 
reform goals and systemic strategies are 
exemplary for other nations that pursue 
UHC.’12 In early 2009, the Chinese govern-
ment launched a new round of health system 
reform with the goal of providing affordable 
and equitable basic healthcare for all by 2020, 
which is in line with the basic concept of UHC 
defined by WHO.13 This year marks the 10th 
anniversary of China’s most recent healthcare 
reform. Evidence from China is especially 
timely for countries pursuing UHC. However, 
much of the early research focused solely on 
the first 3- year reform after 2009 in China, 
summary box
 ► Continued political support is the most important 
enabling condition for achieving universal health 
coverage (UHC). China has shown clear political will-
ingness to make UHC achievement a more country- 
led process.
 ► Increasing health financing is necessary, and the in-
vestment from both government and private sector 
is considered.
 ► A strong primary healthcare system should be re-
garded as a core component in realising UHC. The 
Chinese government has made primary healthcare a 
priority in its ‘Healthy China 2030’ strategy.
 ► Some lessons providing reform experiences for oth-
er countries include the pilot reform and systematic 
reform strategy.
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Table 1 Socioeconomic and health indicators for China and other E7 countries
China India Brazil Mexico Russia Indonesia Turkey
1990 2000 2010 2017 2017
GNI per capita, PPP 
(current international $)*
990 2900 9290 16 800 6950 15 270 18 210 25 120 11 910 27 640
GDP growth (annual %)* 3.91 8.49 10.64 6.90 7.17 1.06 2.04 1.65 5.07 7.44
Human Development Index 
(HDI)†
0.50 0.59 0.71 0.75 0.64 0.76 0.77 0.82 0.69 0.79
Life expectancy at birth, 
total (years)*
69.3 72.0 75.2 76.4 68.8 75.7 77.3 72.1 69.4 76.0
Maternal mortality ratio 
(modelled estimate, per 
100 000 live births)*‡
97 59 36 29 145 60 33 17 177 17
Mortality rate, under-5 (per 
1000 live births)§
53.8 36.8 15.8 9.3 39.4 14.8 13.4 7.6 25.4 11.6
Mortality rate, neonatal 
(per 1000 live births)§
29.5 21.4 8.4 4.7 24 8.5 7.6 3.3 12.4 5.9
The E7 (short for ‘Emerging 7’) is the seven countries, China, India, Brazil, Mexico, Russia, Indonesia and Turkey, grouped together because of their major emerging 
economies (cited in Wikipedia).
*Source: The World Bank.
†Source: United Nations Development Program (UNDP).
‡Source: WHO.
§Source: UNICEF.
GDP, gross domestic product; GNI, gross national income; PPP, purchasing power parity.
without addressing the issue of the reform evolution and 
progress during the past decade. There is inadequate 
understanding of how China moves towards UHC step 
by step. We undertook a literature review, and analysed 
policies and secondary data from governmental sources. 
We aim to share the complete experience and strategy 
about China’s healthcare reform, and provide the critical 
lessons for other nations, especially for LMICs.
AnAlysIs of THe ConTexT
The People’s Republic of China (PRC) covers approx-
imately 9.6 million km2, and is now the most populous 
country in the world with 1.42 billion people.14 The 
urban population accounts for 58.0% of the total popula-
tion.15 PRC was founded on 1 October 1949. At the time, 
China had one of the world’s poorest healthcare delivery 
systems due to an economy weakened by war.16 Today, 
China is an upper middle- income country whose gross 
domestic product has grown substantially at an average 
annual rate of 9.5% over the past 40 years, and has lifted 
more than 850 million people out of poverty.17 With the 
rapid economic growth, China has made great efforts to 
achieve UHC. For example, China has devoted increased 
public funding to health—the largest increase among 
Brazil, Russia, India, China and South Africa countries.18 
China has almost achieved all of the Millennium Devel-
opment Goals (MDG) by 2015, making a major contribu-
tion to the achievement of the MDGs globally, and is now 
moving towards SDGs to achieve UHC by 2030.19 Table 1 
illustrates a summary of key socioeconomic and health 
indicators in the country from 1990 to 2017, as well as the 
comparable data in the other Emerging 7 (E7) countries 
(India, Brazil, Mexico, Russia, Indonesia and Turkey) in 
2017. China has experienced remarkable improvements 
in economic conditions, human development and 
health outcomes, such as life expectancy and mortality. 
Compared with other E7 countries, China is at a relatively 
good level in both its economy and population health.
A revIew of THe reform progress
Since the founding of the PRC in 1949, China has expe-
rienced dramatic changes in its healthcare system. Like 
many other countries, China’s healthcare reform has also 
undergone a difficult exploratory process. Therefore, it 
is necessary to briefly review the progress of reform of the 
healthcare system over the past 70 years. We divide the 
progress of China’s healthcare reform into three stages.
stage 1: 30 years after the founding of people’s republic of 
China (1949–1979)
At the founding of PRC, with a weak foundation, the 
state developed a centrally planned socialist system, 
emphasising public ownership and welfare, mass- based 
collectivism and egalitarianism.20 In the health sector, 
the government managed a centrally directed health 
delivery system, and defined four principles to guide 
health and medical work: (1) serve the workers, peas-
ants and soldiers; (2) put prevention first, in particular 
through the Patriotic Health Campaigns; (3) integrate 
traditional Chinese medicine with Western medicine; 
and (4) combine health work with mass movements.21 22 
These principles of healthcare delivery reform contrib-
uted to rapid improvement in the health of the popu-
lation,23 creating some reform models (eg, ‘Barefoot 
Doctors’,24 ‘Cooperative Medical System’25 and ‘three- 
tier health service delivery system’) that were highly 
valued by the WHO.26 During this period, despite a 
shortage of healthcare resources, China’s healthcare 
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Figure 1 Overall framework and road map of the new round of healthcare reform. *12th Five- Year Plan on deepening the 
medical system reform. **13th Five- Year Plan on deepening the medical system reform.
system achieved almost universal access to healthcare and 
preventive services, producing impressive health gains—
for example, dramatically increased life expectancy and 
decreased infant mortality.27
stage 2: 30 years after the ‘reform and opening up’ policy 
(1979–2009)
Beginning in 1978, China began its ‘reform and open-
ing- up’ policy, ushering in a socialist market economy 
that encouraged a free market and focused on economic 
growth. This led to a fundamental transformation of 
the Chinese healthcare system and had a profound 
impact.28 29 With privatisation and marketisation, the 
changes in the healthcare system included: a shift from 
public financing to private sources; a reorganisation of 
public hospitals and clinics into commercial enterprises; 
decentralising healthcare governance to local govern-
ments; and a pricing policy that enabled facilities to 
gain profits.30 31 These changes helped expand health-
care resources and improve medical technology and 
equipment, but also posed many problems (eg, reduced 
government expenditure on healthcare, less emphasis 
on rural areas and public health, and overutilisation of 
unnecessary or expensive care),32–34 resulting in a series 
of adverse effects, such as increased disparities between 
rural and urban residents, a decline in public health, 
rising healthcare costs and sharp decreases in insur-
ance coverage.23 31 35 In 2003, the severe acute respira-
tory syndrome epidemic revealed weaknesses in China’s 
health system and focused a domestic and international 
spotlight on those weaknesses.36 This wake- up call opened 
a window of opportunity for a new round of healthcare 
reform.
stage 3: the latest round of healthcare reform (2009 to 
present)
With the policy goals of achieving a ‘harmonious 
society’ as a national priority, the Chinese government 
launched a new round of healthcare reform in 2009.37 
It is an unprecedented health system transformation 
towards UHC, aiming to provide universal coverage 
of basic healthcare by the end of 2020.38 39 Following 
extensive interagency consultation and public debates, 
this launch emphasised a return to government- led, 
people- centred healthcare and healthcare as a public 
good. The latest round of healthcare reform adopted 
the ‘best fit’ with the existing institutional and policy 
frameworks towards achieving UHC by an incremental 
approach (step by step), which was recommended by 
the WHO team.40
The ‘Opinions on Deepening the Health Care 
System Reform’ that were promulgated by the Central 
Committee of the Communist Party of China (CPC) and 
the State Council marked the start of China’s new health-
care reform.41 The comprehensive reform plan can be 
summarised as ‘one goal, four beams, and eight columns’ 
(figure 1).42 43 Under the goal of achieving UHC, China 
concentrated on establishing the four systems (ie, public 
health service system, medical service system, health 
insurance system, and drug supply and security system), 
based on the eight functional mechanisms that could 
provide essential supports. Accordingly, three sequen-
tial phases of healthcare reform plans were to be carried 
out to achieve the overall goal by 2020: the 2009–2011 
phase, the 2012–2015 phase and the 2016–2020 phase 
(figure 1).31 44
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Figure 2 The priorities and relationship among the three healthcare reform plans.
The 2009–2011 phase
The first 3- year reform plan laid a foundation for the 
2020 goal. There were five reform priorities: (1) accel-
erating the establishment of a basic health insurance 
system; (2) establishing a preliminary national essential 
drug system; (3) improving the primary care delivery 
system to provide basic healthcare; (4) making basic 
public health services (BPHS) available and equal for 
all; and (5) piloting public hospital reforms.45 46 Reforms 
during this first phase focused on strengthening primary 
care. This phase of reform obtained positive evaluations 
and was confirmed to be heading in the right direction 
by WHO and others.12 47 48
The 2012–2015 phase
The second phase of healthcare reform, China’s ‘12th 
Five- Year Plan’, continued in the same general direction.49 
The reforms were promoted and deepened during this 
period, and clarified three tasks: (1) basic health insur-
ance for all; (2) consolidation and improvement of the 
essential drug system; and (3) reform of public hospitals. 
The focus of reform gradually shifted from primary care 
to the public hospitals, especially county public hospitals. 
The county public hospitals lead the reform of public 
hospitals through subsidising medical services with profit 
from drug sales, and comprehensively promoting the 
reform of the management system, compensation mech-
anism, personnel distribution, procurement mechanism 
and price mechanism.
The 2016–2020 phase
Following the reform tasks specified at the Third Plenary 
Session of the 18th Central Committee of the CPC in 
2013, the ‘13th Five- Year Plan on deepening the health 
care system reform’ marked the beginning of the third 
phase, a comprehensive drive for deeper reform.50 The 
reform of this phase focuses on the transitions from: (1) 
laying a solid foundation to improving quality; (2) frame-
work formation to system construction; and (3) single- 
area breakthroughs to system integration and compre-
hensive promotion. ‘Tripartite System Reform (TSR)’, 
which refers to the linkage reform of the medical care, 
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Table 2 Summary of the main reform initiatives and achievements, 2009 to present
Reform areas Main reform initiatives Achievements
Health insurance 
system
Expanding the population coverage 
of the basic health insurance 
schemes.
More than 95% of the population covered by social health insurance 
schemes in 2018.
  Extending the health service 
package of the basic health 
insurance schemes.
The number of pharmaceuticals on the drug list was expanded to 
2643 in 2019; government subsidies per capita for the URBMI and 
NRCMS have increased more than fivefold in 2018 compared with 
2009.
  Developing the MFA for people 
living in extreme poverty.
In 2018, a total of ¥42.46 billion was spent from medical assistance 
funds nationwide to subsidise 76.739 million people to participate 
in basic medical insurance, and 53.61 million people received 
outpatient and inpatient assistance.
  Developing the CMI for those 
people with catastrophic medical 
expenditure.
Since 2013, CMI has covered 1.01 billion people in China 
and benefited more than 11 million people (60% of whom are 
rural residents), and reimbursement payments have exceeded 
¥30 billion.73
  Integrating basic health insurance 
systems of rural and urban 
residents: merging NRCMS and 
URBMI into the URRMI.
Unifying insurance coverage, funding policies, insured treatment, 
reimbursement catalogues, management of contracted medical 
institutions and fund management: for example, the number of drugs 
covered in the insurance drug list is unified to 2643 in 2019, and the 
per- capita premium is unified to ¥693 in 2018.
  Reforming the payment system. 65% of public hospitals above the second level have carried out 
reforms of the disease category- based insurance payment in 2017; 
announcing a list of 30 pilot cities for DRG payment reform in 2019.
Drug supply and 
security system
Zero mark- up policy on drug sales. All public hospitals nationwide have removed the medicine mark- ups 
in 2017.
  Formulating and expanding the 
NEML.
Issuing a revision of the NEML in 2009 including a list of 307 
essential medicines, and expanding the list to 520 medicines in 2012 
and 685 medicines in 2018.58
  Supplying and evaluating the 
generic drugs.
Publishing the first list of 34 generic drugs on June 2018; as of 28 
August 2019, 313 product specifications have passed the generic 
drug consistency evaluation.74
  Reforming the drug tendering and 
procurement system.
11 pilot provinces and 200 pilot cities have implemented the ‘two 
invoice policy’ tendering system by the end of 2017; the drug 
procurement costs of the corresponding varieties in 11 pilot cities fell 
from ¥7.7 billion to ¥1.9 billion, and the cost dropped by 75.3%.
  Promoting rational use of essential 
drugs.
Rates of antibiotic use in inpatient and outpatient care decreased by 
50% in selected tertiary hospitals.75
Medical service 
system
Increasing investment in the primary 
healthcare system, including 
strengthening the infrastructure of 
PHC facilities.
Government subsidies to PHC institutions have increased 
substantially: from 2009 to 2017, subsidies as a proportion of total 
PHC income increased from 12.3% to 32.5%.76
  Expanding human resources for 
primary care through incentives and 
supporting projects.
Compared with 2012, the total number of primary healthcare workers 
in 2017 increased by 7.1% to 3.863 million, and the number of 
general practitioners per 10 000 population increased from 0.8 to 1.8.
  Developing a tiered service delivery 
system by establishing HCAs 
and providing family practitioners 
contracted services.
Tiered healthcare system started by 95% of municipalities by the 
end of 2017; all 2134 tertiary public hospitals in China participated in 
the establishment of HCAs in 2018.
  Improving pricing policies: removing 
mark- up of drugs as a source of 
finance for all public hospitals, 
increasing the price of medical 
services that can reflect the value of 
medical staffs’ technical services.
In 2017, 27.5% of the medical revenue of public hospitals reflected 
the value of technical services of medical staff (medical service 
income), an increase of 2.8 percentage points over the previous year. 
Drugs and consumables accounted for 48.0% of the total revenue, 
4.2 percentage points lower than the previous year. Among them, the 
proportion of medicines dropped to 34.7%.
Continued
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Reform areas Main reform initiatives Achievements
  Implementing telemedicine to 
improve the delivery of services to 
people living in remote and low- 
income areas.
More than 13 000 medical institutions implemented telemedicine 
services, which have covered all national poverty counties.
Public health 
service system
Providing basic public health service 
package to all people through 
government subsidies.
Increased government public funding was invested to expand the 
services (from 9 categories in 2009 to 14 categories in 2017) and 
availability of the basic public health package to almost everyone; an 
average of ¥15 was allotted per capita in 2009 and was increased to 
¥55 in 2018.
  
  Supporting programmes to control 
the main public health problems.
  
Adapted from Meng et al [62]. Data sources are from the Central People's Government of the People's Republic of China website, the 
National Health Commission website and the National Healthcare Security Administration website.
¥7=US$1.
CMI, Catastrophic Medical Insurance; DRG, diagnosis- related group; HCA, healthcare alliance; MFA, Medical Financial Assistance; NEML, 
National Essential Medicines List; NRCMS, New Rural Cooperative Medical Scheme; PHC, primary healthcare; URBMI, Urban Resident 
Basic Medical Insurance; URRMI, Urban and Rural Resident Medical Insurance.
Table 2 Continued
medical insurance and pharmaceutical industry, became 
the basic principle for comprehensively deepening the 
healthcare reform. It is noteworthy that this phase of 
reform is guided by the ‘Healthy China 2030’ strategy, 
which emphasises ensuring population health for all 
individuals across the life course and integrated Health 
in All Policies.51 52
Figure 2 illustrates the priorities and relationship 
among the three healthcare reform plans.
mAIn reform InITIATIves And ACHIevemenTs of THe pAsT 
deCAde
Health insurance system
Reforming the health insurance system is essential and 
critical since it has served as the major source of financing 
for the healthcare delivery system. Basic health insurance 
in China, including the Urban Employee Basic Medical 
Insurance, the New Rural Cooperative Medical Scheme 
(NRCMS) and the Urban Resident Basic Medical Insur-
ance (URBMI), laid the foundation for universal insur-
ance coverage. Priority was given to expanding the 
scope and health service package of the basic insurance 
coverage, improving provider payment mechanisms, 
as well as increasing the financing level, fiscal subsidies 
and reimbursement rates. To improve equity in access to 
healthcare between rural and urban areas and efficiency 
in operation of the schemes,53 the Chinese government 
consolidated the fragmented health insurance schemes 
by merging NRCMS and URBMI into the Urban and 
Rural Resident Medical Insurance in 2016,54 and then 
established the National Healthcare Security Adminis-
tration in 2018 to implement unified management for 
these insurance schemes. In addition, the government 
launched Medical Financial Assistance in 2003 and Cata-
strophic Medical Insurance in 2012 as supplementary 
medical insurance to provide funds for patients with 
poverty and catastrophic illness.55 The moves, parts of 
‘Health Poverty Alleviation (HPA)’ (a critical element 
of the national Poverty Alleviation Project), are signifi-
cant steps towards ‘Healthy China’ and UHC, protecting 
people with low incomes from impoverishment due to 
exorbitant healthcare costs, and breaking the cycle of 
poverty and illness.55 The payment reform is being imple-
mented to modify the behaviour of providers and to 
control the unreasonable growth of medical expenses—
replacing fee- for- service payment with comprehensive 
payment methods based on disease category.56
drug supply and security system
As the base of drug supply and security system, the 
national essential medicines system reform is compre-
hensive and includes but is not limited to the following: 
the selection, production and distribution of essen-
tial medicines; quality assurance; reasonable pricing; 
tendering and procurement; a zero mark- up policy on 
sales; rational use and reimbursement; and monitoring 
and evaluation.57 The government issued a revision of 
the National Essential Medicines List (NEML) in 2009 
including a list of 307 essential medicines, and constantly 
expands the list to fully meet the needs of basic health-
care.58 These on- list medicines should be available at all 
primary care institutions. To improve access to medi-
cines, China boosted the research and development of 
generic drugs, and required the evaluation of generics 
to prove they are equivalent to the originator products 
in terms of quality and efficacy.59 A ‘two invoice policy’ 
tendering system was developed to avoid higher mark- up 
and reduce circulation during the process of distribu-
tion.60 All medicines in the NEML are included in health 
insurance reimbursement lists, which are reimbursed at 
higher rates compared with non- essential medicines.
medical service system
Establishing a strong primary care delivery system is an 
ongoing priority in China. The government has increased 
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investment in primary care, with initiatives that include 
strengthening the infrastructure of primary healthcare 
(PHC) facilities, expanding human resources for primary 
care through incentives and supporting projects, estab-
lishing a general practitioner system61 and improving 
the capacity of PHC personnel through training and 
education, such as general practice training and contin-
uous medical education programmes. Public hospital 
reforms focus on removing drug mark- ups as a source of 
financing, and rationalising medical service pricing (eg, 
improving the price of medical services that can reflect 
the value of medical staffs’ technical services, and piloting 
the removal of medical consumable mark- ups). Addi-
tionally, the priority task is establishing a tiered health-
care delivery system by developing healthcare alliances 
to improve intersectoral coordination and integration62 
and providing family practitioners contracted services.63 
The development of private hospitals is encouraged to 
increase the supply of healthcare resources. Further, tele-
medicine is promoted to improve the delivery of services 
to people living in remote and poverty areas.
public health service system
The ‘equalization of basic public health services’ policy 
implemented the national BPHS programme and the 
crucial public health service (CPHS) programme. It aims 
to reduce major health risk factors, prevent and control 
major communicable diseases and chronic diseases and 
improve response to public health emergencies.64 This 
policy seeks to achieve universal availability and promote 
a more equitable provision of basic health services to all 
urban and rural citizens. The BPHS set out the minimum 
services for all citizens, including health management 
and monitoring. The service package can be expanded 
by local governments according to local public health 
issues and financial affordability. CPHS seeks to fight 
important infectious diseases (eg, prevention and 
control of tuberculosis, AIDS and bilharziasis) and meet 
the needs of vulnerable groups (eg, breast and cervical 
cancer screening for rural women, cataract surgery for 
low- income patients).65 With a focus on public health and 
prevention, the State Council announced a series of 15 
recommended actions to achieve ‘Healthy China 2030’ 
on 15 July 2019, which include ‘intervening in health 
influencing factors, protecting full- life- cycle health, and 
preventing and controlling major diseases’.66
During the past 10 years since the latest round of health-
care reform, China made steady progress in achieving 
the reform goals and UHC. Table 2 showed the summary 
of the main reform initiatives and achievements.
lessons from CHInA’s experIenCe
Achieving UHC is a tough and long- term task that is 
not unique to China and confronts many other coun-
tries. When pursuing UHC, China adopted the general 
strategies recommended by WHO, and also developed a 
pathway with Chinese characteristics through healthcare 
reform. The experience from China may provide invalu-
able lessons for other countries.
First, continued political support is the most important 
enabling condition for achieving UHC. Efforts through 
national- level initiatives of different governments show 
that the political will to drive better healthcare is crucial, 
such as the 2017 National Health Policy in India and 
Rwanda’s Vision 2020.67 China’s commitment to UHC 
remains unchanged since the healthcare reform in 2009, 
and progress through three phases step by step focusing 
on the overall goal. CPC and governments at all levels 
have shown clear political willingness to reach the goal 
by 2030, making UHC achievement a more country- led 
process. In 2016, President Xi Jinping announced 
‘Healthy China 2030 Blueprint’, a national long- term 
strategy in health sector that sets ambitious targets for 
China.
Second, increasing health financing is necessary, 
and the investment from both government and private 
sectors is considered. At the initial phase of the health-
care reform, on the basis of limited financial fund, 
Chinese government increased investment in health-
care infrastructure and greatly increased the coverage 
of health insurances, achieving the universal coverage 
maximally. After years of exploration during the reform 
process, it was realised that China should strike a proper 
balance between the government and the market—play 
the government’s leading role in providing basic health 
services, and at the same time, introduce appropriate 
competition mechanisms to energise the market in non- 
basic health services, encouraging the private sector to 
provide multilevel and diversified medical services.
Third, a strong PHC system should be regarded as a 
core component in realising UHC. Along with the new 
Declaration of Astana, PHC for health as a global priority 
is the pathway to reach the SDGs and UHC.68 In the 
early days, some experience in PHC in China demon-
strated that ‘health for all’ is a practical possibility, for 
example, the ‘Patriotic Health Campaign’ and ‘Barefoot 
Doctors’.69 The ‘Patriotic Health Campaign’ encouraged 
everyone to participate in public health activities, and 
aimed to improve sanitation, hygiene, health education, 
as well as combat infectious diseases.70 Engagement of 
civil society is necessary to promote UHC. The ‘Barefoot 
Doctors’ model used limited medical resources to provide 
common disease diagnosis and prevention services to a 
large rural population. However, the Chinese healthcare 
system created adverse consequences after market- based 
reforms, in part due to a weakening of support for PHC.71 
Today, recognising the importance of revamping its PHC 
system, the Chinese government has made PHC a priority 
in its ‘Healthy China 2030’ strategy.
In addition to these general lessons, there are also 
some lessons with Chinese characteristics, providing 
reform experiences for other countries: (1) China’s 
health reforms are usually piloted and then rolled out 
nationwide, such as the public hospital reform; or the 
reform started from the grass level and then refined for 
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the nation, such as the Sanming model.72 (2) In the latest 
phase of reform, China is paying more attention to the 
systemic and linkage reform (ie, TSR). This innovative 
strategy can help promote the dynamic balance among 
medical care, medical insurance and medicine, and 
construct a coordinating healthcare system to achieve 
UHC.
ConClusIon
A strength of our study was that we systematically and 
comprehensively assessed healthcare reform in the past 
decade moving towards UHC in China, including evolu-
tion, initiatives and achievements. The lessons learnt 
from China could help other nations improve UHC in 
sustainable and adaptive ways, including continued polit-
ical support, increased health financing and a strong 
PHC system as basis. The experience of the rapid devel-
opment of UHC in China can provide a valuable mode 
for countries (mainly LMICs) planning their own path 
further on in the UHC journey.
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